Canadian researchers have studied it in models of tendon repair, gastrointestinal healing, muscle recovery, and neuroprotection
Combined with KPV, whose intestinal anti-inflammatory effects have been demonstrated in colitis models, Klow could be of interest for digestive health
Body weight of the test subjects was measured when the patients were screened, when they were randomly assigned to treatment groups, and at weeks 2, 4, 6, 8, 10, 14, 18, 22, 26, and 32 [1]
The peptide sequence, derived from human growth hormone, appears sufficiently similar to native proteins that the immune system does not mount a response against it
Most protocols deliver 1 to 3 mg per day subcutaneously, either daily or 5 days on with 2 days off